Heart Rhythm Society Scientific Sessions
In this video, David Conen, MD, MPH, provides insight into the results of the Swiss Atrial Fibrillation Cohort (Swiss-AF) trial and what they reveal about the incidence of clinically silent brain infarcts among patients with AF who are receiving anticoagulation therapy.
Although long-term oral anticoagulation therapy can significantly reduce thromboembolic complications among patients with atrial fibrillation, adherence to therapy can be challenging. Researchers evaluated whether a smartwatch can improve adherence. The findings were shared during Heart Rhythm Society 2020 Science.
Though current guidelines recommend antiplatelet therapy for patients with cryptogenic stroke, new research is examining the effect of anticoagulation therapy on patient outcomes. Researcher Hooman Kamel, MD, from Weill Cornell Medical School, answers our questions about this debate.
In this podcast, Jordana Kron, MD, from Virginia Commonwealth University, discusses cardiac sarcoidosis screening and diagnostic criteria, as well as how cardiologists can overcome the challenges associated with screening for and diagnosing cardiac sarcoidosis.